Cancer spheroids and organoids as novel tools for research and therapy: state of the art and challenges to guide precision medicine

S El Harane, B Zidi, N El Harane, KH Krause, T Matthes… - Cells, 2023 - mdpi.com
Spheroids and organoids are important novel players in medical and life science research.
They are gradually replacing two-dimensional (2D) cell cultures. Indeed, three-dimensional …

Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution

A Rodriguez-Meira, R Norfo, S Wen, AL Chédeville… - Nature …, 2023 - nature.com
Understanding the genetic and nongenetic determinants of tumor protein 53 (TP53)-
mutation-driven clonal evolution and subsequent transformation is a crucial step toward the …

Generating human bone marrow organoids for disease modeling and drug discovery

AA Olijnik, A Rodriguez-Romera, ZC Wong, Y Shen… - Nature …, 2024 - nature.com
The bone marrow supports and regulates hematopoiesis, responding to physiological
requirements for blood cell production over ontogeny and during pathological challenges …

Human bone marrow organoids for disease modeling, discovery, and validation of therapeutic targets in hematologic malignancies

AO Khan, A Rodriguez-Romera, JS Reyat, AA Olijnik… - Cancer discovery, 2023 - AACR
A lack of models that recapitulate the complexity of human bone marrow has hampered
mechanistic studies of normal and malignant hematopoiesis and the validation of novel …

Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy

S Sobrino, A Magnani, M Semeraro, L Martignetti… - Cell Reports …, 2023 - cell.com
X-linked chronic granulomatous disease (CGD) is associated with defective phagocytosis,
life-threatening infections, and inflammatory complications. We performed a clinical trial of …

MARVEL: an integrated alternative splicing analysis platform for single-cell RNA sequencing data

WX Wen, AJ Mead, S Thongjuea - Nucleic Acids Research, 2023 - academic.oup.com
Alternative splicing is an important source of heterogeneity underlying gene expression
between individual cells but remains an understudied area due to the paucity of …

Temporal molecular program of human hematopoietic stem and progenitor cells after birth

Y Zhang, X Xie, Y Huang, M Liu, Q Li, J Luo, Y He… - Developmental Cell, 2022 - cell.com
Hematopoietic stem and progenitor cells (HSPCs) give rise to the blood system and
maintain hematopoiesis throughout the human lifespan. Here, we report a transcriptional …

Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging

NA Jakobsen, S Turkalj, AGX Zeng, B Stoilova… - Cell Stem Cell, 2024 - cell.com
Clonal hematopoiesis (CH) arises when hematopoietic stem cells (HSCs) acquire mutations,
most frequently in the DNMT3A and TET2 genes, conferring a competitive advantage …

CD34+CD19CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies

C Bueno, S Barrera, A Bataller… - Blood, The Journal …, 2022 - ashpublications.org
CD19-directed immunotherapies have revolutionized the treatment of advanced B-cell acute
lymphoblastic leukemia (B-ALL). Despite initial impressive rates of complete remission (CR) …

[HTML][HTML] Intratumoral erythroblastic islands restrain anti-tumor immunity in hepatoblastoma

Y Wang, X Xiang, H Chen, L Zhou, S Chen… - Cell Reports …, 2023 - cell.com
Erythroblastic islands (EBIs) are the specialized structures for erythropoiesis, but they have
never been found functional in tumors. As the most common pediatric liver malignancy …